TuHURA Biosciences, Inc.

NasdaqCM:HURA Stock Report

Market Cap: US$83.8m

TuHURA Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HURA?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,159,4945.1%
Private Companies5,145,16412.2%
General Public15,653,03637%
Individual Insiders19,363,91545.8%

Dilution of Shares: HURA only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 62.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.9%
Vijay Patel
7,999,557US$15.8m-67.2%no data
6.08%
KP Biotech Group, LLC
2,572,582US$5.1m0%no data
6.08%
CA Patel F&F Investments, LLC
2,572,582US$5.1m0%no data
5.92%
Charles Theofilos
2,506,321US$5.0m-77.4%no data
5.83%
Samir Patel
2,466,377US$4.9m-76%no data
5.49%
James Bianco
2,323,307US$4.6m-85.1%no data
4.81%
Michael Lawman
2,036,410US$4.0m-82.4%no data
4.8%
Patricia Lawman
2,030,089US$4.0m-82.4%no data
1.12%
ClearArc Capital, Inc.
473,559US$937.6k0%no data
0.92%
BlackRock, Inc.
391,307US$774.8k0%no data
0.89%
The Vanguard Group, Inc.
376,319US$745.1k0%no data
0.63%
Geode Capital Management, LLC
264,915US$524.5k0%no data
0.24%
Suncoast Equity Management, LLC
102,997US$203.9k0%0.03%
0.22%
UBS Asset Management AG
93,333US$184.8k0%no data
0.15%
Citigroup Inc.,Banking and Securities Investments
65,013US$128.7k0%no data
0.15%
Apollon Wealth Management, LLC
61,772US$122.3k0%no data
0.14%
Northern Trust Global Investments
57,248US$113.4k0%no data
0.13%
Squarepoint OPS LLC
54,535US$108.0k0%no data
0.098%
Hurlow Wealth Management Group, Inc.
41,444US$82.1k0%0.03%
0.08%
Millennium Management LLC
33,808US$66.9k0%no data
0.074%
OMERS Administration Corporation
31,400US$62.2k0%no data
0.054%
State Street Global Advisors, Inc.
23,006US$45.6k0%no data
0.035%
Charles Schwab Investment Management, Inc.
15,000US$29.7k0%no data
0.034%
Bank of America Corporation, Asset Management Arm
14,314US$28.3k0%no data
0.031%
Jefferies Financial Group Inc.,Asset Management Arm
13,200US$26.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 19:31
End of Day Share Price 2025/03/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

TuHURA Biosciences, Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BurnsH.C. Wainwright & Co.
Jason McCarthyMaxim Group
John VandermostenZacks Small-Cap Research